| Net Cash Provided by (Used in) Operating Activities |
$2,000,596 |
USD |
-9.2% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$822,362 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$500,000 |
USD |
-24434% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
150,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
4,527,412 |
shares |
234% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,445,427 |
USD |
-93% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$33,015,029 |
USD |
9.2% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$27,074,956 |
USD |
-197% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$35,200,000 |
USD |
12% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$84,531,703 |
USD |
56% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$1,032 |
USD |
-26% |
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
$14,709 |
USD |
-96% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |